Advanced search
Publication Cover
Biomarkers in Medicine Volume 4, 2010 - Issue 1
Submit an article Journal homepage
304
Views
1
CrossRef citations to date
0
Altmetric
Theme: Alzheimer's disease: the biomarker revolution - Review

Biomarkers in Alzheimer's Disease: Past, Present and Future

Katarzyna Gustaw-Rothenberg1 University Hospitals, Case Medical Center and University Memory and Cognition Center,Case Western Reserve University,Cleveland,OH,USA;2 Department of Neurodegenerative Diseases,Institute of Agricultural Medicine,2 Jaczewskiego Str,20-095,Lublin,Poland
,
Alan Lerner1 University Hospitals, Case Medical Center and University Memory and Cognition Center,Case Western Reserve University,Cleveland,OH,USA
,
David J Bonda3 Department of Pathology,Case Western Reserve University,Cleveland,OH,USA.
,
Hyoung-gon Lee3 Department of Pathology,Case Western Reserve University,Cleveland,OH,USA.
,
Xiongwei Zhu3 Department of Pathology,Case Western Reserve University,Cleveland,OH,USA.
,
George Perry3 Department of Pathology,Case Western Reserve University,Cleveland,OH,USA.;4 UTSA Neurosciences Institute and Department of Biology, College of Sciences,University of Texas at San Antonio,San Antonio,TX,USA
&
Mark A Smith3 Department of Pathology,Case Western Reserve University,Cleveland,OH,USA.Correspondence[email protected]
 show all
Pages 15-26 | Published online: 02 Feb 2010

Bibliography

  • McKhann G , DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.Neurology34(7) , 939–944 (1984).
  • Dubois B , FeldmanHH, JacovaC et al.: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.Lancet Neurol.6(8) , 734–746 (2007).
  • Swets JA : Measuring the accuracy of diagnostic systems.Science240(4857) , 1285–1293 (1988).
  • Evans DA , FunkensteinHH, AlbertMS et al.: Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.JAMA262(18) , 2551–2556 (1989).
  • Lerner AJ , FriedlandRP, WhitehousePJ: Uses of biological markers.Alzheimer Dis. Assoc. Disord.6(4) , 197–200 (1992).
  • Risacher SL , SaykinAJ, WestJD, ShenL, FirpiHA, McDonaldBC: Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.Curr. Alzheimer Res.6(4) , 347–361 (2009).
  • Landau SM , HarveyD, MadisonCM et al.: Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.Neurobiol. Aging (2010) (Epub ahead of print).
  • Leow AD , YanovskyI, ParikshakN et al.: Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.Neuroimage45(3) , 645–655 (2009).
  • Querbes O , AubryF, ParienteJ et al.: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.Brain132(Pt 8) , 2036–2047 (2009).
  • Folstein MF , FolsteinSE, McHughPR: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician.J. Psychiatr. Res.12(3) , 189–198 (1975).
  • Mohs RC , CohenL: Alzheimer's Disease Assessment Scale (ADAS).Psychopharmacol. Bull.24(4) , 627–628 (1988).
  • Ray S , BritschgiM, HerbertC et al.: Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.Nat. Med.13(11) , 1359–1362 (2007).
  • Hardy J , SelkoeDJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.Science297(5580) , 353–356 (2002).
  • Castellani RJ , NunomuraA, LeeHG, PerryG, SmithMA: Phosphorylated tau: toxic, protective, or none of the above.J. Alzheimers Dis.14(4) , 377–383 (2008).
  • Brouwers N , SleegersK, Van BroeckhovenC: Molecular genetics of Alzheimer's disease: an update. Ann. Med.40(8) , 562–583 (2008).
  • Martinez-Garcia A , AldudoJ, RecueroM et al.: Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein ε4 carriers.Dement. Geriatr. Cogn. Disord.26(5) , 440–444 (2008).
  • McShea A , LeeHG, PetersenRB et al.: Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.Biochim. Biophys. Acta1772, 467–472 (2007).
  • Moreira PI , SantosMS, OliveiraCR et al.: Alzheimer disease and the role of free radicals in the pathogenesis of the disease.CNS Neurol. Disord. Drug Targets7(1) , 3–10 (2008).
  • Wang X , SuB, ZhengL, PerryG, SmithMA, ZhuX: The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.J. Neurochem.109(Suppl. 1) , 153–159 (2009).
  • Smith MA : Alzheimer disease.Int. Rev. Neurobiol.42, 1–54 (1998).
  • Roychaudhuri R , YangM, HoshiMM, TeplowDB: Amyloid β-protein assembly and Alzheimer disease.J. Biol. Chem.284(8) , 4749–4753 (2009).
  • Lee HG , ZhuX, NunomuraA, PerryG, SmithMA: Amyloid β: the alternate hypothesis.Curr. Alzheimer Res.3(1) , 75–80 (2006).
  • Castellani RJ , LeeHG, ZhuX, NunomuraA, PerryG, SmithMA: Neuropathology of Alzheimer disease: pathogenomonic but not pathogenic.Acta Neuropathol. (Berl.)111(6) , 503–509 (2006).
  • Lee HG , CasadesusG, ZhuX, JosephJA, PerryG, SmithMA: Perspectives on the amyloid-β cascade hypothesis.J. Alzheimers Dis.6(2) , 137–145 (2004).
  • Sousa MM , SaraivaMJ: Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.Prog. Neurobiol.71(5) , 385–400 (2003).
  • Selkoe DJ : Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein.J. Alzheimers Dis.3(1) , 75–80 (2001).
  • Greenberg SM , KooEH, SelkoeDJ, QiuWQ, KosikKS: Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.Proc. Natl Acad. Sci. USA91(15) , 7104–7108 (1994).
  • Clark CM , KarlawishJH: Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.Ann. Intern. Med.138(5) , 400–410 (2003).
  • Craft JM , WattersonDM, HirschE, Van EldikLJ: Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid. J. Neuroinflammation2, 15 (2005).
  • Weksler ME , RelkinN, TurkenichR, LaRusseS, ZhouL, SzaboP: Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals.Exp. Gerontol.37(7) , 943–948 (2002).
  • Du Y , DodelR, HampelH et al.: Reduced levels of amyloid β-peptide antibody in Alzheimer disease.Neurology57(5) , 801–805 (2001).
  • Mruthinti S , BuccafuscoJJ, HillWD et al.: Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Aβ and RAGE peptides.Neurobiol. Aging25(8) , 1023–1032 (2004).
  • Biere AL , OstaszewskiB, StimsonER, HymanBT, MaggioJE, SelkoeDJ: Amyloid β-peptide is transported on lipoproteins and albumin in human plasma.J. Biol. Chem.271(51) , 32916–32922 (1996).
  • Sagare A , DeaneR, BellRD et al.: Clearance of amyloid-β by circulating lipoprotein receptors.Nat. Med.13(9) , 1029–1031 (2007).
  • Fullwood NJ , HayashiY, AllsopD: Plasma amyloid-β concentrations in Alzheimer's disease: an alternative hypothesis.Lancet Neurol.5(12) , 1000–1001; author reply 1002–1003 (2006).
  • Oh ES , TroncosoJC, Fangmark TuckerSM: Maximizing the potential of plasma amyloid-β as a diagnostic biomarker for Alzheimer's disease. Neuromolecular Med.10(3) , 195–207 (2008).
  • Blennow K : Cerebrospinal fluid protein biomarkers for Alzheimer's disease.NeuroRx1(2) , 213–225 (2004).
  • Schenk D , BarbourR, DunnW et al.: Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature400(6740) , 173–177 (1999).
  • Wilcock DM , GordonMN, UgenKE et al.: Number of Aβ inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels.DNA Cell Biol.20(11) , 731–736 (2001).
  • Gustaw KA , GarrettMR, LeeHG et al.: Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis.J. Neurochem.106(3) , 1350–1356 (2008).
  • Li Q , CaoC, ChackerianB et al.: Overcoming antigen masking of anti-amyloid-β antibodies reveals breaking of B cell tolerance by virus-like particles in amyloid-β immunized amyloid precursor protein transgenic mice.BMC Neurosci.5, 21 (2004).
  • Gustaw-Rothenberg KA , SiedlakSL, BondaDJ et al.: Dissociated amyloid-β antibody levels during the progression of Alzheimer's disease: a population-based study.Exp. Gerontol.45, 47–52 (2010).
  • Ida N , HartmannT, PantelJ et al.: Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay.J. Biol. Chem.271(37) , 22908–22914 (1996).
  • Quesada JJ , FerrucciL, CalvaniD, ValenteC, SalaniB, BavazzanoA: Formal education as an effect modifier of the relationship between Mini-Mental State Examination score and IADLs disability in the older population.Aging (Milano)9(3) , 175–179 (1997).
  • Iqbal K , ZaidiT, ThompsonCH, MerzPA, WisniewskiHM: Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition.Acta Neuropathol. (Berl.)62(3) , 167–177 (1984).
  • Grundke-Iqbal I , IqbalK, TungYC, QuinlanM, WisniewskiHM, BinderLI: Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology.Proc. Natl Acad. Sci. USA83(13) , 4913–4917 (1986).
  • Lee HG , PerryG, MoreiraPI et al.: Tau phosphorylation in Alzheimer's disease: pathogen or protector?Trends Mol. Med.11(4) , 164–169 (2005).
  • Alonso AC , Grundke-IqbalI, IqbalK: Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.Nat. Med.2(7) , 783–787 (1996).
  • Cash AD , AlievG, SiedlakSL et al.: Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.Am. J. Pathol.162(5) , 1623–1627 (2003).
  • Brion JP , PassarierH, NunezJ, Flament-DurandJ: Immunologic determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease.Arch. Biol.95, 229–235 (1985).
  • Kanemaru K , TakioK, MiuraR, TitaniK, IharaY: Fetal-type phosphorylation of the tau in paired helical filaments.J. Neurochem.58(5) , 1667–1675 (1992).
  • Goedert M , JakesR, CrowtherRA et al.: The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.Proc. Natl Acad. Sci. USA90(11) , 5066–5070 (1993).
  • Pope WB , LambertMP, LeypoldB et al.: Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.Exp. Neurol.126(2) , 185–194 (1994).
  • Arendt T , HolzerM, GrossmannA, ZedlickD, BrucknerMK: Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.Neuroscience68(1) , 5–18 (1995).
  • Vincent I , RosadoM, DaviesP: Mitotic mechanisms in Alzheimer's disease?J. Cell Biol.132(3) , 413–425 (1996).
  • Ledesma MD , CorreasI, AvilaJ, Diaz-NidoJ: Implication of brain Cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease.FEBS Lett.308(2) , 218–224 (1992).
  • Baumann K , MandelkowEM, BiernatJ, Piwnica-WormsH, MandelkowE: Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.FEBS Lett.336(3) , 417–424 (1993).
  • McShea A , WahlAF, SmithMA: Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.Med. Hypotheses52(6) , 525–527 (1999).
  • Zhu X , RottkampCA, RainaAK et al.: Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease.Neurobiol. Aging21(6) , 807–813 (2000).
  • Raina AK , ZhuX, RottkampCA, MonteiroM, TakedaA, SmithMA: Cyclin’ toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease.J. Neurosci. Res.61(2) , 128–133 (2000).
  • Hampel H , BroichK, HoesslerY, PantelJ: Biological markers for early detection and pharmacological treatment of Alzheimer's disease.Dialogues Clin. Neurosci.11(2) , 141–157 (2009).
  • Heckmann JM , LowWC, de VilliersCet al.: Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease. Brain127(Pt 1) , 133–142 (2004).
  • Wong PC , ZhengH, ChenH et al.: Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm.Nature387(6630) , 288–292 (1997).
  • Struhl G , GreenwaldI: Presenilin is required for activity and nuclear access of Notch in Drosophila.Nature398(6727) , 522–525 (1999).
  • Ye Y , LukinovaN, FortiniME: Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants.Nature398(6727) , 525–529 (1999).
  • Wodarz A , NusseR: Mechanisms of Wnt signaling in development.Annu. Rev. Cell Dev. Biol.14, 59–88 (1998).
  • Polakis P : The oncogenic activation of β-catenin.Curr. Opin. Genet. Dev.9(1) , 15–21 (1999).
  • Janicki SM , MonteiroMJ: Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant.Am. J. Pathol.155(1) , 135–144 (1999).
  • Mattson MP , GuoQ, FurukawaK, PedersenWA: Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease.J. Neurochem.70(1) , 1–14 (1998).
  • Lindwall G , ColeRD: Phosphorylation affects the ability of tau protein to promote microtubule assembly.J. Biol. Chem.259(8) , 5301–5305 (1984).
  • Wolozin B , IwasakiK, VitoP et al.: Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.Science274(5293) , 1710–1713 (1996).
  • Park DS , MorrisEJ, PadmanabhanJ, ShelanskiML, GellerHM, GreeneLA: Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents.J. Cell Biol.143(2) , 457–467 (1998).
  • Giovanni A , Wirtz-BruggerF, KeramarisE, SlackR, ParkDS: Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in β-amyloid-induced neuronal death.J. Biol. Chem.274(27) , 19011–19016 (1999).
  • Carter DB : The interaction of amyloid-β with ApoE.Subcell. Biochem.38, 255–272 (2005).
  • Farrer LA , CupplesLA, HainesJL et al.: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.JAMA278(16) , 1349–1356 (1997).
  • Van Duijn CM , ClaytonDG, ChandraV et al.: Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case–control studies. EURODEM Risk Factors Research Group.Genet. Epidemiol.11(6) , 539–551 (1994).
  • Potkin SG , GuffantiG, LakatosA et al.: Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.PLoS ONE4(8) , e6501 (2009).
  • Markesbery WR : Oxidative stress hypothesis in Alzheimer's disease.Free Radic. Biol. Med.23(1) , 134–147 (1997).
  • Barni S , SciolaL, SpanoA, PippiaP: Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts.Biotech. Histochem.71(2) , 66–70 (1996).
  • Hirai K , AlievG, NunomuraA et al.: Mitochondrial abnormalities in Alzheimer's disease.J. Neurosci.21(9) , 3017–3023 (2001).
  • Sousa M , BarrosA, SilvaJ, TesarikJ: Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos.Mol. Hum. Reprod.3(2) , 83–90 (1997).
  • Zhu X , LeeHG, PerryG, SmithMA: Alzheimer disease, the two-hit hypothesis: an update.Biochim. Biophys. Acta1772(4) , 494–502 (2007).
  • Ferrer I , BlancoR, CarmonaM, PuigB: Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.J. Neural Transm.108(12) , 1397–1415 (2001).
  • Zhu X , LeeHG, RainaAK, PerryG, SmithMA: The role of mitogen-activated protein kinase pathways in Alzheimer's disease.Neurosignals11(5) , 270–281 (2002).
  • Zhang L , JopeRS: Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells.Neurobiol. Aging20(3) , 271–278 (1999).
  • Smith MA , SayreLM, MonnierVM, PerryG: Radical AGEing in Alzheimer's disease.Trends Neurosci.18(4) , 172–176 (1995).
  • Luo Y , BondJD, IngramVM: Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases.Proc. Natl Acad. Sci. USA94(18) , 9705–9710 (1997).
  • Takeda A , PerryG, AbrahamNG et al.: Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau.J. Biol. Chem.275(8) , 5395–5399 (2000).
  • Zhu X , RainaAK, PerryG, SmithMA: Alzheimer's disease: the two-hit hypothesis.Lancet Neurol.3(4) , 219–226 (2004).
  • Zhu X , CastellaniRJ, TakedaA et al.: Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis.Mech. Ageing Dev.123(1) , 39–46 (2001).
  • Nagy ZS , SmithMZ, EsiriMM, BarnetsonL, SmithAD: Hyperhomocysteinaemia in Alzheimer's disease and expression of cell cycle markers in the brain.J. Neurol. Neurosurg. Psychiatry69(4) , 565–566 (2000).
  • Elledge SJ : Cell cycle checkpoints: preventing an identity crisis.Science274(5293) , 1664–1672 (1996).
  • Padmanabhan J , ParkDS, GreeneLA, ShelanskiML: Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis.J. Neurosci.19(20) , 8747–8756 (1999).
  • Gartner U , HolzerM, ArendtT: Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration.Neuroscience91(1) , 1–5 (1999).
  • Lee HG , CasadesusG, NunomuraA et al.: The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.Am. J. Pathol.174(3) , 891–897 (2009).
  • McShea A , LeeHG, PetersenRB et al.: Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.Biochim. Biophys. Acta1772(4) , 467–472 (2007).
  • Ledoux S , RebaiN, DagenaisA et al.: Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation.J. Immunol.150(12) , 5566–5575 (1993).
  • Suzuki T , OishiM, MarshakDR, CzernikAJ, NairnAC, GreengardP: Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein.EMBO J.13(5) , 1114–1122 (1994).
  • Whitson JS , SelkoeDJ, CotmanCW: Amyloid-β protein enhances the survival of hippocampal neurons in vitro.Science243(4897) , 1488–1490 (1989).
  • McDonald DR , BambergerME, CombsCK, LandrethGE: β-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.J. Neurosci.18(12) , 4451–4460 (1998).
  • Rapoport M , FerreiraA: PD98059 prevents neurite degeneration induced by fibrillar β-amyloid in mature hippocampal neurons.J. Neurochem.74(1) , 125–133 (2000).
  • Busser J , GeldmacherDS, HerrupK: Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.J. Neurosci.18, 2801–2807 (1998).
  • Koliatsos VE : Biological therapies for Alzheimer's disease: focus on trophic factors.Crit. Rev. Neurobiol.10(2) , 205–238 (1996).
  • Stopa EG , GonzalezAM, ChorskyR et al.: Basic fibroblast growth factor in Alzheimer's disease.Biochem. Biophys. Res. Commun.171(2) , 690–696 (1990).
  • Crutcher KA , ScottSA, LiangS, EversonWV, WeingartnerJ: Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease.J. Neurosci.13(6) , 2540–2550 (1993).
  • van der Wal EA , Gomez-PinillaF, CotmanCW: Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies.Neuroreport4(1) , 69–72 (1993).
  • Lesort M , JohnsonGV: Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons.Neuroscience99(2) , 305–316 (2000).
  • Russell JW , WindebankAJ, SchenoneA, FeldmanEL: Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.J. Neurobiol.36(4) , 455–467 (1998).
  • Raina AK , HochmanA, ZhuX et al.: Abortive apoptosis in Alzheimer's disease.Acta Neuropathol. (Berl).101(4) , 305–310 (2001).
  • Yang Y , MufsonEJ, HerrupK: Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease.J. Neurosci.23(7) , 2557–2563 (2003).
  • Spremo-Potparevic B , ZivkovicL, DjelicN, Plecas-SolarovicB, SmithMA, BajicV: Premature centromere division of the X chromosome in neurons in Alzheimer's disease.J. Neurochem.106(5) , 2218–2223 (2008).
  • Bowser R , SmithMA: Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle.J. Alzheimers Dis.4(3) , 249–254 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.